• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名早产儿的围产期低磷酸酯酶症

Perinatal Hypophosphatasia in a Premature Infant.

作者信息

Sankaran Deepika, Chandrasekharan Praveen K, Rawat Munmun

机构信息

Department of Pediatrics, University of California, Davis, Sacramento, California.

Department of Pediatrics, University at Buffalo, Buffalo, New York.

出版信息

AJP Rep. 2020 Apr;10(2):e139-e147. doi: 10.1055/s-0040-1709512. Epub 2020 Apr 15.

DOI:10.1055/s-0040-1709512
PMID:32309015
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7159980/
Abstract

A premature male infant was delivered at 32 weeks' gestation due to category-2 fetal tracing after preterm labor. The physical exam showed shortened and bowed long bones, with calvarium felt in small area of the head. Serum alkaline phosphatase was very low on admission. Extensive metaphyseal abnormalities, bowing of long bones, and poor ossification of all bones were noted on skeletal survey (radiography). Based on ultrasound evidence of "bowing" and long bone fractures at 26 weeks, amniocentesis was performed that later diagnosed hypophosphatasia by genetic testing while ruling out osteogenesis imperfecta. Although ventilated initially, the infant gradually improved with enzyme replacement therapy (ERT) and was extubated to noninvasive ventilation for 6 weeks. Following clinical deterioration with hypoxic respiratory failure secondary to sepsis at 4 months of age, he succumbed to severe pulmonary hypertension, likely secondary to chronic lung disease and prolonged ventilation. Early diagnosis allowed timely initiation of appropriate therapy. Radiological improvement with the therapy showed promising results in this rare disease. Despite specific novel therapy being available, variability in presentation dictates prognosis in this previously universally fatal condition. The potential unknown effects of ERT on pulmonary vascular remodeling need further investigation.

摘要

一名早产男婴在孕32周时因早产先兆出现2类胎儿监护情况而分娩。体格检查发现长骨缩短且弯曲,头部小面积可摸到颅骨。入院时血清碱性磷酸酶非常低。骨骼检查(X线摄影)显示广泛的干骺端异常、长骨弯曲以及所有骨骼骨化不良。基于26周时超声显示的“弯曲”和长骨骨折证据,进行了羊膜穿刺术,后来通过基因检测诊断为低磷酸酯酶症,同时排除了成骨不全症。尽管最初需要通气,但婴儿通过酶替代疗法(ERT)逐渐好转,并在无创通气下维持了6周。在4个月大时,因败血症继发缺氧性呼吸衰竭导致临床病情恶化,最终死于严重的肺动脉高压,可能继发于慢性肺病和长时间通气。早期诊断使得能够及时开始适当的治疗。治疗后的影像学改善在这种罕见疾病中显示出有希望的结果。尽管有特定的新疗法,但临床表现的差异决定了这种以前普遍致命疾病的预后。ERT对肺血管重塑的潜在未知影响需要进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d42/7159980/7d28d17116c3/10-1055-s-0040-1709512-i190069-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d42/7159980/169fc8c32ea0/10-1055-s-0040-1709512-i190069-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d42/7159980/45a34badc68c/10-1055-s-0040-1709512-i190069-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d42/7159980/1ddb963f40e4/10-1055-s-0040-1709512-i190069-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d42/7159980/5f1cf412002c/10-1055-s-0040-1709512-i190069-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d42/7159980/8f3c10846994/10-1055-s-0040-1709512-i190069-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d42/7159980/7d28d17116c3/10-1055-s-0040-1709512-i190069-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d42/7159980/169fc8c32ea0/10-1055-s-0040-1709512-i190069-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d42/7159980/45a34badc68c/10-1055-s-0040-1709512-i190069-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d42/7159980/1ddb963f40e4/10-1055-s-0040-1709512-i190069-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d42/7159980/5f1cf412002c/10-1055-s-0040-1709512-i190069-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d42/7159980/8f3c10846994/10-1055-s-0040-1709512-i190069-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d42/7159980/7d28d17116c3/10-1055-s-0040-1709512-i190069-6.jpg

相似文献

1
Perinatal Hypophosphatasia in a Premature Infant.一名早产儿的围产期低磷酸酯酶症
AJP Rep. 2020 Apr;10(2):e139-e147. doi: 10.1055/s-0040-1709512. Epub 2020 Apr 15.
2
Dental effects of enzyme replacement therapy in case of childhood-type hypophosphatasia.儿童型低磷酸酯酶症酶替代疗法的牙齿影响
BMC Oral Health. 2021 Jun 27;21(1):323. doi: 10.1186/s12903-021-01673-2.
3
Enzyme-replacement therapy in perinatal hypophosphatasia: Case report and review of the literature.围生期低磷酸酯酶症的酶替代疗法:病例报告及文献综述
Arch Pediatr. 2018 Oct;25(7):442-447. doi: 10.1016/j.arcped.2018.08.002. Epub 2018 Sep 21.
4
Differential diagnosis of perinatal hypophosphatasia: radiologic perspectives.围产期低磷酸酯酶症的鉴别诊断:放射学观点
Pediatr Radiol. 2019 Jan;49(1):3-22. doi: 10.1007/s00247-018-4239-0. Epub 2018 Oct 3.
5
Six-year clinical outcomes of enzyme replacement therapy for perinatal lethal and infantile hypophosphatasia in Korea: Two case reports.韩国围生期致死性和婴儿型低磷酸酯酶症酶替代治疗的 6 年临床结果:两例病例报告。
Medicine (Baltimore). 2023 Feb 10;102(6):e32800. doi: 10.1097/MD.0000000000032800.
6
Lethal hypophosphatasia successfully treated with enzyme replacement from day 1 after birth.出生后第1天起采用酶替代疗法成功治疗致死性低磷酸酯酶症。
Eur J Pediatr. 2016 Mar;175(3):433-7. doi: 10.1007/s00431-015-2641-2. Epub 2015 Oct 12.
7
Hypophosphatasia: the importance of alkaline phosphatase in bone mineralization.低磷酸酯酶症:碱性磷酸酶在骨矿化中的重要性。
J Med Assoc Thai. 1999 Dec;82(12):1268-72.
8
Case Report: Efficacy of Reduced Doses of Asfotase Alfa Replacement Therapy in an Infant With Hypophosphatasia Who Lacked Severe Clinical Symptoms.病例报告:在一名缺乏严重临床症状的低磷酸酶血症婴儿中,减少阿法特酶替代治疗剂量的疗效。
Front Endocrinol (Lausanne). 2020 Dec 18;11:590455. doi: 10.3389/fendo.2020.590455. eCollection 2020.
9
Hypophosphatasia in a newborn infant.
Turk J Pediatr. 1995 Jan-Mar;37(1):61-5.
10
Hypophosphatasia.低磷酸酯酶症
Orphanet J Rare Dis. 2007 Oct 4;2:40. doi: 10.1186/1750-1172-2-40.

引用本文的文献

1
The levels of pro- and anti-inflammatory cytokines in premature infants with perinatal infections.围生期感染早产儿促炎和抗炎细胞因子水平。
Mol Cell Biochem. 2022 Feb;477(2):621-625. doi: 10.1007/s11010-021-04314-y. Epub 2021 Dec 3.

本文引用的文献

1
Hypophosphatasia: A Novel Mutation Associated with an Atypical Newborn Presentation.低磷酸酯酶症:一种与非典型新生儿表现相关的新型突变。
J Clin Res Pediatr Endocrinol. 2020 Mar 19;12(1):104-108. doi: 10.4274/jcrpe.galenos.2019.2018.0263. Epub 2019 Apr 1.
2
Efficacy and Safety of Asfotase Alfa in Infants and Young Children With Hypophosphatasia: A Phase 2 Open-Label Study.阿法特司治疗婴儿和幼儿低磷酸酯酶症的疗效和安全性:一项 2 期开放标签研究。
J Clin Endocrinol Metab. 2019 Jul 1;104(7):2735-2747. doi: 10.1210/jc.2018-02335.
3
Differential diagnosis of perinatal hypophosphatasia: radiologic perspectives.
围产期低磷酸酯酶症的鉴别诊断:放射学观点
Pediatr Radiol. 2019 Jan;49(1):3-22. doi: 10.1007/s00247-018-4239-0. Epub 2018 Oct 3.
4
Laboratory diagnosis of hypophosphatasia.低磷酸酯酶症的实验室诊断
Arch Pediatr. 2017 May;24(5S2):5S57-5S60. doi: 10.1016/S0929-693X(18)30015-0.
5
Hypophosphatasia.低磷酸酯酶症。
Metabolism. 2018 May;82:142-155. doi: 10.1016/j.metabol.2017.08.013. Epub 2017 Sep 20.
6
Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa.阿法特酶治疗低磷酸酯酶症患者的监测指导。
Mol Genet Metab. 2017 Sep;122(1-2):4-17. doi: 10.1016/j.ymgme.2017.07.010. Epub 2017 Jul 25.
7
Hypophosphatasia: Enzyme Replacement Therapy Brings New Opportunities and New Challenges.低磷酸酯酶症:酶替代治疗带来新机遇和新挑战。
J Bone Miner Res. 2017 Apr;32(4):667-675. doi: 10.1002/jbmr.3075. Epub 2017 Jan 31.
8
Hypophosphatasia: Natural history study of 101 affected children investigated at one research center.低磷性骨软化症:在一个研究中心对101名患病儿童进行的自然史研究。
Bone. 2016 Dec;93:125-138. doi: 10.1016/j.bone.2016.08.019. Epub 2016 Aug 27.
9
Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia.阿法骨化醇治疗可提高围产期和婴儿期低磷酸酯酶症的生存率。
J Clin Endocrinol Metab. 2016 Jan;101(1):334-42. doi: 10.1210/jc.2015-3462. Epub 2015 Nov 3.
10
Clinical characteristics of perinatal lethal hypophosphatasia: a report of 6 cases.围生期致死性低磷酸酯酶症的临床特征:6例报告
Clin Pediatr Endocrinol. 2010 Jan;19(1):7-13. doi: 10.1297/cpe.19.7. Epub 2010 Mar 11.